Skip to main content

Table 1 Patient characteristics: baseline parameters

From: Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hocanalysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial

  Placebo (n = 13) rFVIIa (n = 17)
Female, number (percentage) 5 (38) 7 (41)
Age, years 32.6 ± 16.8 33.5 ± 13.7
Injury Severity Score 36.8 ± 12.8 38.7 ± 13.7
Abbreviated Injury Score head (region 1) 3 [3-5] 3 [3-5]
Mean arterial pressure, mm Hg 76 ± 22 71 ± 18 (n = 16)
Body temperature, °C 35.1 ± 1.3 (n = 8) 34.3 ± 1.8 (n = 9)
pH 7.24 ± 0.12 (n = 11) 7.22 ± 0.10 (n = 15)
  1. Baseline refers to predosing. All data are presented as number of patients (percentage) or mean (± standard deviation shown in most cases) or median [minimum-maximum shown], and n is indicated in cases in which there are missing values. rFVIIa, recombinant activated factor VII.